- Home
- OFS vs LNZA Comparison
OFS vs LNZA Comparison
Compare OFS & LNZA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | OFS | LNZA |
|---|---|---|
| Founded | 2001 | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance/Investors Services | Major Chemicals |
| Sector | Finance | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 54.3M | 61.2M |
| IPO Year | 2010 | 2021 |
Fundamental Metrics
Financial Performance| Metric | OFS | LNZA |
|---|---|---|
| Price | $3.60 | $6.32 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $14.00 |
| AVG Volume (30 Days) | 51.4K | ★ 62.4K |
| Earning Date | 04-30-2026 | 05-18-2026 |
| Dividend Yield | ★ 16.83% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 17.00 |
| Revenue | N/A | ★ $55,845,000.00 |
| Revenue This Year | N/A | $55.80 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $0.37 |
| Revenue Growth | N/A | ★ 12.61 |
| 52 Week Low | $2.72 | $5.02 |
| 52 Week High | $8.99 | $44.00 |
Technical Indicators
Market Signals| Indicator | OFS | LNZA |
|---|---|---|
| Relative Strength Index (RSI) | 50.44 | 51.85 |
| Support Level | $3.57 | $5.38 |
| Resistance Level | $4.06 | $6.50 |
| Average True Range (ATR) | 0.18 | 0.42 |
| MACD | -0.00 | 0.07 |
| Stochastic Oscillator | 44.23 | 61.96 |
Price Performance
Historical ComparisonAbout OFS OFS Capital Corporation
OFS Capital Corp is an externally managed, closed-end, non-diversified management investment company. Its investment objective is to provide its stockholders with both current income and capital appreciation through debt investments and, to a lesser extent, equity investments.
About LNZA LanzaTech Global Inc.
LanzaTech Global Inc is a provider of carbon management and conversion technologies, focused on transforming waste materials into high-value fuels, chemicals, and critical industrial inputs. Its mission is to drive energy resilience, industrial competitiveness, and supply chain security by leveraging scalable biotechnology solutions to maximize the value of domestic resources. The company operates in North America, Europe, the Middle East, Africa (EMEA), Asia, and Australia, with the majority of its revenue generated from North America.